India will procure 20 more doses of monoclonal antibody for the treatment of Nipah virus infection from Australia, ICMR Director-General Rajeev Bahl said on Friday.
“We got some doses of monoclonal antibody from Australia in 2018. Currently the doses are available for only 10 patients,” he said.
According to him, no one so far has been administered the medicine in India.